Eric Vallabh Minikel, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prion Diseases | 13 | 2023 | 88 | 5.230 |
Why?
|
| Prions | 8 | 2023 | 181 | 2.360 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2023 | 433 | 1.710 |
Why?
|
| Genes, Essential | 2 | 2020 | 182 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 5 | 2022 | 1060 | 0.790 |
Why?
|
| Age of Onset | 2 | 2019 | 3266 | 0.730 |
Why?
|
| Penetrance | 3 | 2019 | 380 | 0.660 |
Why?
|
| Anticipation, Genetic | 1 | 2014 | 5 | 0.510 |
Why?
|
| Benzimidazoles | 1 | 2020 | 848 | 0.510 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 721 | 0.490 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2014 | 89 | 0.480 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2016 | 587 | 0.450 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2203 | 0.410 |
Why?
|
| Bicycling | 1 | 2011 | 176 | 0.360 |
Why?
|
| Transportation | 1 | 2011 | 211 | 0.350 |
Why?
|
| Environment Design | 1 | 2011 | 178 | 0.350 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2723 | 0.330 |
Why?
|
| Genetic Variation | 6 | 2020 | 6540 | 0.310 |
Why?
|
| Safety | 1 | 2011 | 1185 | 0.280 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 819 | 0.270 |
Why?
|
| Urban Population | 1 | 2011 | 2018 | 0.220 |
Why?
|
| Gene Frequency | 3 | 2020 | 3587 | 0.220 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 3076 | 0.200 |
Why?
|
| PrPC Proteins | 1 | 2021 | 37 | 0.200 |
Why?
|
| Heterozygote | 4 | 2020 | 2790 | 0.190 |
Why?
|
| Brain | 5 | 2023 | 26343 | 0.190 |
Why?
|
| Mutation | 6 | 2020 | 29717 | 0.190 |
Why?
|
| Cerebrospinal Fluid | 1 | 2023 | 534 | 0.180 |
Why?
|
| Oligonucleotides | 1 | 2023 | 572 | 0.180 |
Why?
|
| Sample Size | 2 | 2020 | 844 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2023 | 2335 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2023 | 518 | 0.170 |
Why?
|
| Consanguinity | 1 | 2020 | 456 | 0.160 |
Why?
|
| Automation | 1 | 2020 | 584 | 0.150 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 908 | 0.150 |
Why?
|
| Jews | 1 | 2018 | 385 | 0.140 |
Why?
|
| Rare Diseases | 2 | 2018 | 554 | 0.140 |
Why?
|
| Genome, Human | 3 | 2020 | 4420 | 0.140 |
Why?
|
| Mice | 6 | 2023 | 81045 | 0.140 |
Why?
|
| Genotype | 2 | 2022 | 12946 | 0.140 |
Why?
|
| Autoantigens | 1 | 2020 | 891 | 0.130 |
Why?
|
| Homozygote | 1 | 2020 | 1777 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3862 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.130 |
Why?
|
| RNA | 2 | 2023 | 2747 | 0.130 |
Why?
|
| Drug Discovery | 2 | 2020 | 1057 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1372 | 0.130 |
Why?
|
| Exons | 1 | 2020 | 2431 | 0.120 |
Why?
|
| Humans | 27 | 2022 | 742088 | 0.110 |
Why?
|
| Animals | 9 | 2023 | 168561 | 0.110 |
Why?
|
| Craniosynostoses | 1 | 2017 | 400 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2023 | 1970 | 0.110 |
Why?
|
| Autoantibodies | 1 | 2020 | 2036 | 0.100 |
Why?
|
| Artifacts | 1 | 2020 | 1903 | 0.100 |
Why?
|
| Acceleration | 1 | 2011 | 181 | 0.090 |
Why?
|
| Databases, Genetic | 4 | 2020 | 1780 | 0.090 |
Why?
|
| tau Proteins | 1 | 2020 | 1860 | 0.090 |
Why?
|
| Genome | 1 | 2019 | 1803 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3760 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 19862 | 0.090 |
Why?
|
| Motor Vehicles | 1 | 2011 | 268 | 0.090 |
Why?
|
| Cell Line | 2 | 2020 | 15994 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1786 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 615 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6534 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 2017 | 1912 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 21821 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2699 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17400 | 0.070 |
Why?
|
| California | 1 | 2011 | 1400 | 0.070 |
Why?
|
| Risk Factors | 4 | 2021 | 72145 | 0.070 |
Why?
|
| Pedigree | 1 | 2014 | 4646 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4801 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3020 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2011 | 802 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2018 | 2301 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12344 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2023 | 12164 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2016 | 3439 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7901 | 0.060 |
Why?
|
| Research Design | 1 | 2019 | 5979 | 0.060 |
Why?
|
| Rats | 1 | 2019 | 24265 | 0.060 |
Why?
|
| Phenotype | 5 | 2020 | 16331 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21719 | 0.050 |
Why?
|
| Female | 10 | 2020 | 379592 | 0.050 |
Why?
|
| Male | 9 | 2020 | 349538 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2014 | 6191 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 56350 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 40450 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2021 | 437 | 0.050 |
Why?
|
| Proteins | 1 | 2015 | 6096 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57683 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 543 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2014 | 5100 | 0.040 |
Why?
|
| Child | 2 | 2019 | 77478 | 0.040 |
Why?
|
| Adolescent | 2 | 2019 | 85649 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 2400 | 0.040 |
Why?
|
| Adult | 5 | 2020 | 213712 | 0.040 |
Why?
|
| Aged | 4 | 2020 | 162944 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12071 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 2014 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 213127 | 0.040 |
Why?
|
| Facies | 1 | 2017 | 197 | 0.040 |
Why?
|
| Polyradiculoneuropathy | 1 | 2016 | 67 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 468 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2016 | 151 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2019 | 981 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 707 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3127 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2018 | 933 | 0.030 |
Why?
|
| Endonucleases | 1 | 2016 | 381 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2020 | 1294 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 810 | 0.030 |
Why?
|
| Longevity | 1 | 2020 | 1069 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 18006 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1792 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2020 | 2614 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 6474 | 0.030 |
Why?
|
| Haplotypes | 1 | 2018 | 2781 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2016 | 748 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1636 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2016 | 1538 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9735 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 12220 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 6608 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2015 | 1118 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1538 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 2751 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2011 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3493 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4187 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9387 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1790 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2020 | 2774 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2016 | 2924 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 77098 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6931 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12773 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 13029 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13921 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3518 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3585 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14720 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 18112 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15194 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5655 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9410 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15494 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 13853 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35070 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15108 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 40955 | 0.010 |
Why?
|